Skip to main content
Erschienen in: European Journal of Nutrition 1/2014

01.02.2014 | Original Contribution

Effects of high-tryptophan diet on pre- and postnatal development in rats: a morphological study

verfasst von: Paola Castrogiovanni, Giuseppe Musumeci, Francesca Maria Trovato, Rosanna Avola, Gaetano Magro, Rosa Imbesi

Erschienen in: European Journal of Nutrition | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Tryptophan is an essential amino acid, precursor of serotonin. Serotonin (5HT) regulates the secretion of pituitary growth hormone (GH), which in turn stimulates the liver to produce insulin-like growth factor-I (IGF-I) that is necessary for development and growth. The aim of our study was to investigate the effects of an excess of tryptophan in the diet of pregnant rats on the differentiation of skeletal muscle tissue.

Methods

We conducted an immunohistochemical study on the IGF-I expression in hepatic and muscle tissues in offspring, and then, we associated this molecular data with morphological effects on the structure of the muscle fibers and hepatic tissue at different postnatal weeks, from birth to sexual maturity. Measurements of 5HT, GH in blood, and of tryptophan hydroxylase (Tph) activity in gastrointestinal tracts tissue were also taken.

Results

Hyperserotonemia and higher values of Tph activity were detected in both pregnant rats and pups. Very low levels of GH were detected in experimental pups. Morphological alterations of the muscle fibers and lower IGF-I expression in hepatic and muscle tissue in pups were found.

Conclusions

Our data suggest that an excess of tryptophan in the diet causes hyperserotonemia in fetus. Hyperserotonemia results in an excess of serotonin in the brain where it has an adverse effect on the development of serotonergic neurons. The affected neurons do not regulate optimally the secretion of pituitary GH that consequently decreases. This limits stimulation in the liver to produce IGF-I, crucial for development and growth of pups.
Literatur
1.
Zurück zum Zitat Mateos SS, Sánchez CL, Paredes SD, Barriga C, Rodríguez AB (2009) Circadian levels of serotonin in plasma and brain after oral administration of tryptophan in rats. Basic Clin Pharmacol Toxicol 104:52–59CrossRef Mateos SS, Sánchez CL, Paredes SD, Barriga C, Rodríguez AB (2009) Circadian levels of serotonin in plasma and brain after oral administration of tryptophan in rats. Basic Clin Pharmacol Toxicol 104:52–59CrossRef
2.
Zurück zum Zitat Choi S, DiSilvio B, Fernstrom MH, Fernstrom JD (2011) The chronic ingestion of diets containing different proteins produces marked variations in brain tryptophan levels and serotonin synthesis in the rat. Neurochem Res 36:559–565CrossRef Choi S, DiSilvio B, Fernstrom MH, Fernstrom JD (2011) The chronic ingestion of diets containing different proteins produces marked variations in brain tryptophan levels and serotonin synthesis in the rat. Neurochem Res 36:559–565CrossRef
3.
Zurück zum Zitat Young S (1986) The clinical psychopharmacology of tryptophan. In: Wurtman RJ, Wurtman JJ (eds), New York Young S (1986) The clinical psychopharmacology of tryptophan. In: Wurtman RJ, Wurtman JJ (eds), New York
4.
Zurück zum Zitat Racke K, Reimann A, Schwörer H, Kilbinger H (1995) Regulation of 5-HT release from enterochromaffin cells. Behav Brain Res 73:83–87CrossRef Racke K, Reimann A, Schwörer H, Kilbinger H (1995) Regulation of 5-HT release from enterochromaffin cells. Behav Brain Res 73:83–87CrossRef
5.
Zurück zum Zitat Whitaker-Azmitia PM (2001) Serotonin and brain development: role in human developmental diseases. Brain Res Bull 56:479–485CrossRef Whitaker-Azmitia PM (2001) Serotonin and brain development: role in human developmental diseases. Brain Res Bull 56:479–485CrossRef
6.
Zurück zum Zitat Catalano M (2001) Functionally gene-linked polymorphic regions and genetically controlled neurotransmitters metabolism. Eur Neuropsychopharmacol 11:431–439CrossRef Catalano M (2001) Functionally gene-linked polymorphic regions and genetically controlled neurotransmitters metabolism. Eur Neuropsychopharmacol 11:431–439CrossRef
7.
Zurück zum Zitat Lesch KP (2001) Variation of serotonergic gene expression: neurodevelopment and the complexity of response to psychopharmacologic drugs. Eur Neuropsychopharmacol 11:457–474CrossRef Lesch KP (2001) Variation of serotonergic gene expression: neurodevelopment and the complexity of response to psychopharmacologic drugs. Eur Neuropsychopharmacol 11:457–474CrossRef
8.
Zurück zum Zitat Arnold MA, Fernstrom JD (1978) Serotonin receptor antagonists block a natural, short term surge in serum growth hormone levels. Endocrinology 103:1159–1163CrossRef Arnold MA, Fernstrom JD (1978) Serotonin receptor antagonists block a natural, short term surge in serum growth hormone levels. Endocrinology 103:1159–1163CrossRef
9.
Zurück zum Zitat Collu R, Du Rusisseau P, Taché Y (1979) Role of putative neurotransmitters in prolactin, GH and LH response to acute immobilization stress in male rats. Neuroendocrinology 28:178–186CrossRef Collu R, Du Rusisseau P, Taché Y (1979) Role of putative neurotransmitters in prolactin, GH and LH response to acute immobilization stress in male rats. Neuroendocrinology 28:178–186CrossRef
10.
Zurück zum Zitat Rabii J, Buonomo F, Scanes CG (1981) Role of serotonin in the regulation of growth hormone and prolactin secretion in the domestic fowl. J Endocrinol 90:355–358CrossRef Rabii J, Buonomo F, Scanes CG (1981) Role of serotonin in the regulation of growth hormone and prolactin secretion in the domestic fowl. J Endocrinol 90:355–358CrossRef
11.
Zurück zum Zitat Casanueva FF, Villanueva L, Peñalva A, Cabezas-Cerrato J (1984) Depending on the stimulus, central serotoninergic activation by fenfluramine blocks or does not alter growth hormone secretion in man. Neuroendocrinology 38:302–308CrossRef Casanueva FF, Villanueva L, Peñalva A, Cabezas-Cerrato J (1984) Depending on the stimulus, central serotoninergic activation by fenfluramine blocks or does not alter growth hormone secretion in man. Neuroendocrinology 38:302–308CrossRef
12.
Zurück zum Zitat Hall TR, Harvey S, Chadwick A (1984) Serotonin and acetylcholine affect the release of prolactin and growth hormone from pituitary glands of domestic fowl in vitro in the presence of hypothalamic tissue. Acta Endocrinol (Copenh) 105:455–462 Hall TR, Harvey S, Chadwick A (1984) Serotonin and acetylcholine affect the release of prolactin and growth hormone from pituitary glands of domestic fowl in vitro in the presence of hypothalamic tissue. Acta Endocrinol (Copenh) 105:455–462
13.
Zurück zum Zitat Westlund KN, Childs GV (1982) Localization of serotonin fibers in the rat adenohypophysis. Endocrinology 111:1761–1763CrossRef Westlund KN, Childs GV (1982) Localization of serotonin fibers in the rat adenohypophysis. Endocrinology 111:1761–1763CrossRef
14.
Zurück zum Zitat Léránth C, Palkovits M, Krieger DT (1983) Serotonin immunoreactive nerve fibers and terminals in the rat pituitary–light- and electron-microscopic studies. Neuroscience 9:289–296CrossRef Léránth C, Palkovits M, Krieger DT (1983) Serotonin immunoreactive nerve fibers and terminals in the rat pituitary–light- and electron-microscopic studies. Neuroscience 9:289–296CrossRef
15.
Zurück zum Zitat Payette RF, Gershon MD, Nunez EA (1985) Serotonergic elements of the mammalian pituitary. Endocrinology 116:1933–1942CrossRef Payette RF, Gershon MD, Nunez EA (1985) Serotonergic elements of the mammalian pituitary. Endocrinology 116:1933–1942CrossRef
16.
Zurück zum Zitat López F, Gónzalez D, Aguilar E (1986) Serotonin stimulates GH secretion through a direct pituitary action: studies in hypophysectomized autografted animals and in perifused pituitaries. Acta Endocrinol (Copenh) 113:317–322 López F, Gónzalez D, Aguilar E (1986) Serotonin stimulates GH secretion through a direct pituitary action: studies in hypophysectomized autografted animals and in perifused pituitaries. Acta Endocrinol (Copenh) 113:317–322
17.
Zurück zum Zitat Saland LC (2001) The mammalian pituitary intermediate lobe: an update on innervation and regulation. Brain Res Bull 54:587–593CrossRef Saland LC (2001) The mammalian pituitary intermediate lobe: an update on innervation and regulation. Brain Res Bull 54:587–593CrossRef
18.
Zurück zum Zitat Camarero G, Avendano C, Fernandez-Moreno C, Villar A, Contreras J, de Pablo F, Pichel JG, Varela-Nieto I (2001) Delayed inner ear maturation and neuronal loss in postnatal Igf-1-deficient mice. J Neurosci 21:7630–7641 Camarero G, Avendano C, Fernandez-Moreno C, Villar A, Contreras J, de Pablo F, Pichel JG, Varela-Nieto I (2001) Delayed inner ear maturation and neuronal loss in postnatal Igf-1-deficient mice. J Neurosci 21:7630–7641
19.
Zurück zum Zitat Duan C, Ren H, Gao S (2010) Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: roles in skeletal muscle growth and differentiation. Gen Comp Endocrinol 167:344–351CrossRef Duan C, Ren H, Gao S (2010) Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: roles in skeletal muscle growth and differentiation. Gen Comp Endocrinol 167:344–351CrossRef
20.
Zurück zum Zitat Holt RI (2002) Fetal programming of the growth hormone-insulin-like growth factor axis. Trends Endocrinol Metab 13:392–397CrossRef Holt RI (2002) Fetal programming of the growth hormone-insulin-like growth factor axis. Trends Endocrinol Metab 13:392–397CrossRef
21.
Zurück zum Zitat Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA (1993) IGF-I is required for normal embryonic growth in mice. Genes Dev 7:2609–2617CrossRef Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA (1993) IGF-I is required for normal embryonic growth in mice. Genes Dev 7:2609–2617CrossRef
22.
Zurück zum Zitat Le Roith D, Scavo L, Butler A (2001) What is the role of circulating IGF-I? Trends Endocrinol Metab 12:48–52CrossRef Le Roith D, Scavo L, Butler A (2001) What is the role of circulating IGF-I? Trends Endocrinol Metab 12:48–52CrossRef
23.
Zurück zum Zitat Cassano M, Quattrocelli M, Crippa S, Perini I, Ronzoni F, Sampaolesi M (2009) Cellular mechanisms and local progenitor activation to regulate skeletal muscle mass. J Muscle Res Cell Motil 30:243–253CrossRef Cassano M, Quattrocelli M, Crippa S, Perini I, Ronzoni F, Sampaolesi M (2009) Cellular mechanisms and local progenitor activation to regulate skeletal muscle mass. J Muscle Res Cell Motil 30:243–253CrossRef
24.
Zurück zum Zitat D’Ercole AJ, Ye P, O’Kusky JR (2002) Mutant mouse models of insulin-like growth factor actions in the central nervous system. Neuropeptides 36:209–220CrossRef D’Ercole AJ, Ye P, O’Kusky JR (2002) Mutant mouse models of insulin-like growth factor actions in the central nervous system. Neuropeptides 36:209–220CrossRef
25.
Zurück zum Zitat Wood AW, Duan C, Bern HA (2005) Insulin-like growth factor signaling in fish. Int Rev Cytol 243:215–228CrossRef Wood AW, Duan C, Bern HA (2005) Insulin-like growth factor signaling in fish. Int Rev Cytol 243:215–228CrossRef
26.
Zurück zum Zitat Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59–72 Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59–72
27.
Zurück zum Zitat Harel Z, Tannenbaum GS (1995) Long-term alterations in growth hormone and insulin secretion after temporary dietary protein restriction in early life in the rat. Pediatr Res 38:747–753CrossRef Harel Z, Tannenbaum GS (1995) Long-term alterations in growth hormone and insulin secretion after temporary dietary protein restriction in early life in the rat. Pediatr Res 38:747–753CrossRef
28.
Zurück zum Zitat Whitaker-Azmitia PM (2005) Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism? Int J Dev Neurosci 23:75–83CrossRef Whitaker-Azmitia PM (2005) Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism? Int J Dev Neurosci 23:75–83CrossRef
29.
Zurück zum Zitat Janusonis S (2005) Serotonergic paradoxes of autism replicated in a simple mathematical model. Medl Hypotheses 64:742–750CrossRef Janusonis S (2005) Serotonergic paradoxes of autism replicated in a simple mathematical model. Medl Hypotheses 64:742–750CrossRef
30.
Zurück zum Zitat Hranilovic D, Blazevic S, Ivica N, Cicin-Sain L, Oreskovic D (2011) The effects of the perinatal treatment with 5-hydroxytryptophan or tranylcypromine on the peripheral and central serotonin homeostasis in adult rats. Neurochem Int 59:202–207CrossRef Hranilovic D, Blazevic S, Ivica N, Cicin-Sain L, Oreskovic D (2011) The effects of the perinatal treatment with 5-hydroxytryptophan or tranylcypromine on the peripheral and central serotonin homeostasis in adult rats. Neurochem Int 59:202–207CrossRef
31.
Zurück zum Zitat Lowry OH, Rosebrough NJ, Farr AL, Randal RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275 Lowry OH, Rosebrough NJ, Farr AL, Randal RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
32.
Zurück zum Zitat Musumeci G, Carnazza M, Leonardi R, Loreto C (2012) Expression of beta-defensin-4 in “an in vivo and ex vivo model” of human osteoarthritic knee meniscus. Knee Surg Sports Traumatol Arthrosc 20:216–222CrossRef Musumeci G, Carnazza M, Leonardi R, Loreto C (2012) Expression of beta-defensin-4 in “an in vivo and ex vivo model” of human osteoarthritic knee meniscus. Knee Surg Sports Traumatol Arthrosc 20:216–222CrossRef
33.
Zurück zum Zitat Loreto C, Lo Castro E, Musumeci G, Loreto F, Rapisarda G, Rezzani R, Castorina S, Leonardi R, Rusu MC (2012) Aquaporin 1 expression in human temporomandibular disc. Acta Histochem 114:744–748CrossRef Loreto C, Lo Castro E, Musumeci G, Loreto F, Rapisarda G, Rezzani R, Castorina S, Leonardi R, Rusu MC (2012) Aquaporin 1 expression in human temporomandibular disc. Acta Histochem 114:744–748CrossRef
34.
Zurück zum Zitat Leonardi R, Loreto C, Talic N, Caltabiano R, Musumeci G (2012) Immunolocalization of lubricin in the rat periodontal ligament during experimental tooth movement. Acta Histochem 114:700–704CrossRef Leonardi R, Loreto C, Talic N, Caltabiano R, Musumeci G (2012) Immunolocalization of lubricin in the rat periodontal ligament during experimental tooth movement. Acta Histochem 114:700–704CrossRef
35.
Zurück zum Zitat Musumeci G, Loreto C, Clementi G, Fiore CE, Martinez G (2011) An in vivo experimental study on osteopenia in diabetic rats. Acta Histochem 113:619–625CrossRef Musumeci G, Loreto C, Clementi G, Fiore CE, Martinez G (2011) An in vivo experimental study on osteopenia in diabetic rats. Acta Histochem 113:619–625CrossRef
36.
Zurück zum Zitat Pichler K, Loreto C, Leonardi R, Reuber T, Weinberg AM, Musumeci G (2013) In rat with glucocorticoid-induced osteoporosis, RANKL is downregulated in bone cells by physical activity (treadmill and vibration stimulation training). Histol Histopathol (in press) Pichler K, Loreto C, Leonardi R, Reuber T, Weinberg AM, Musumeci G (2013) In rat with glucocorticoid-induced osteoporosis, RANKL is downregulated in bone cells by physical activity (treadmill and vibration stimulation training). Histol Histopathol (in press)
37.
Zurück zum Zitat Musumeci G, Loreto C, Leonardi R, Castorina S, Giunta S, Carnazza ML, Trovato FM, Pichler K, Weinberg AM (2013) The effects of physical activity on apoptosis and lubricin expression in articular cartilage in rats with glucocorticoid-induced osteoporosis. Bone and Mineral Research (in press) Musumeci G, Loreto C, Leonardi R, Castorina S, Giunta S, Carnazza ML, Trovato FM, Pichler K, Weinberg AM (2013) The effects of physical activity on apoptosis and lubricin expression in articular cartilage in rats with glucocorticoid-induced osteoporosis. Bone and Mineral Research (in press)
38.
Zurück zum Zitat Imbesi R, Castrogiovanni P (2008) Embryonic and postnatal development in experimental tryptophan deprived rats. A preliminary study. J Mol Histol 39:487–498CrossRef Imbesi R, Castrogiovanni P (2008) Embryonic and postnatal development in experimental tryptophan deprived rats. A preliminary study. J Mol Histol 39:487–498CrossRef
39.
Zurück zum Zitat Blazevic S, Dolenec P, Hranilovic D (2011) Physiological consequences of perinatal treatment of rats with 5-hydroxytryptophan. Periodicum Biologorum 113:81–86 Blazevic S, Dolenec P, Hranilovic D (2011) Physiological consequences of perinatal treatment of rats with 5-hydroxytryptophan. Periodicum Biologorum 113:81–86
40.
Zurück zum Zitat Duan C (1998) Nutritional and developmental regulation of insulin-like growth factors in fish. J Nutr 128:306S–314S Duan C (1998) Nutritional and developmental regulation of insulin-like growth factors in fish. J Nutr 128:306S–314S
41.
Zurück zum Zitat Maki R (2010) Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer. J Clin Oncol 28:4985–4995CrossRef Maki R (2010) Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer. J Clin Oncol 28:4985–4995CrossRef
42.
Zurück zum Zitat Raap D, Van de Kar L (1999) Selective serotonin reuptake inhibitors and neuroendocrine function. Life Sci 65:1217–1235CrossRef Raap D, Van de Kar L (1999) Selective serotonin reuptake inhibitors and neuroendocrine function. Life Sci 65:1217–1235CrossRef
43.
Zurück zum Zitat Davies K, Richardson G, Akmentin W, Acuff V, Fenstermacher J (1996) The microarchitecture of cerebral vessels. In: Courad P, Scherman D (eds) The cerebral vascular symposium, biology and physiology of the blood-brain barrier. Plenum Press, New York Davies K, Richardson G, Akmentin W, Acuff V, Fenstermacher J (1996) The microarchitecture of cerebral vessels. In: Courad P, Scherman D (eds) The cerebral vascular symposium, biology and physiology of the blood-brain barrier. Plenum Press, New York
44.
Zurück zum Zitat Philippou A, Maridaki M, Halapas A, Koutsilieris M (2007) The role of the insulin-like growth factor 1 (IGF-1) in skeletal muscle physiology. In Vivo 21:45–54 Philippou A, Maridaki M, Halapas A, Koutsilieris M (2007) The role of the insulin-like growth factor 1 (IGF-1) in skeletal muscle physiology. In Vivo 21:45–54
45.
Zurück zum Zitat Scicchitano BM, Rizzuto E, Musarò A (2009) Counteracting muscle wasting in aging and neuromuscular diseases: the critical role of IGF-1. Aging (Albany NY) 1:451–457 Scicchitano BM, Rizzuto E, Musarò A (2009) Counteracting muscle wasting in aging and neuromuscular diseases: the critical role of IGF-1. Aging (Albany NY) 1:451–457
Metadaten
Titel
Effects of high-tryptophan diet on pre- and postnatal development in rats: a morphological study
verfasst von
Paola Castrogiovanni
Giuseppe Musumeci
Francesca Maria Trovato
Rosanna Avola
Gaetano Magro
Rosa Imbesi
Publikationsdatum
01.02.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 1/2014
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-013-0528-4

Weitere Artikel der Ausgabe 1/2014

European Journal of Nutrition 1/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Chronisches Koronarsyndrom: Gefahr von Hospitalisierung wegen Herzinsuffizienz

06.05.2024 Herzinsuffizienz Nachrichten

Obwohl ein rezidivierender Herzinfarkt bei chronischem Koronarsyndrom wahrscheinlich die Hauptsorge sowohl der Patienten als auch der Ärzte ist, sind andere Ereignisse womöglich gefährlicher. Laut einer französischen Studie stellt eine Hospitalisation wegen Herzinsuffizienz eine größere Gefahr dar.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

06.05.2024 Insomnie Nachrichten

Chronische Insomnie als eigenständiges Krankheitsbild ernst nehmen und adäquat nach dem aktuellen Forschungsstand behandeln: Das forderte der Schlafmediziner Dr. Dieter Kunz von der Berliner Charité beim Praxis Update.

GLP-1-Rezeptoragonisten und SGLT-2-Hemmer: zusammen besser

06.05.2024 Typ-2-Diabetes Nachrichten

Immer häufiger wird ein Typ-2-Diabetes sowohl mit einem GLP-1-Rezeptor-Agonisten als auch mit einem SGLT-2-Inhibitor behandelt. Wie sich das verglichen mit den Einzeltherapien auf kardiovaskuläre und renale Komplikationen auswirkt, wurde anhand von Praxisdaten aus Großbritannien untersucht.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.